Outlook Therapeutics share price today
(OTLK)
Outlook Therapeutics share price is $2.37 & ₹203.37 as on 7 Jan 2025, 2.30 'hrs' IST
$2.37
▲
0.13
(5.8%)
Market is closed - opens 8 PM, 07 Jan 2025
View live Outlook Therapeutics share price in Dollar and Rupees. Guide to invest in Outlook Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Outlook Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Outlook Therapeutics share price movements
- Today's Low: $2.24Today's High: $2.59
5.49%
Downside
Day's Volatility :13.52%
Upside
8.49%
- 52 Weeks Low: $0.8752 Weeks High: $12.85
63.29%
Downside
52 Weeks Volatility :93.23%
Upside
81.56%
Outlook Therapeutics Returns
Outlook Therapeutics Key Statistics
in dollars & INR
How to invest in Outlook Therapeutics from India?
It is very easy for Indian residents to invest directly in Outlook Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Outlook Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Outlook Therapeutics or OTLK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Outlook Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Outlook Therapeutics shares which would translate to 0.362 fractional shares of Outlook Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Outlook Therapeutics, in just a few clicks!
Returns in Outlook Therapeutics for Indian investors in Rupees
Investment Value
₹1,00,000
Outlook Therapeutics investment value today
Current value as on today
₹34,407
Returns
Returns from Outlook Therapeutics Stock
Dollar Returns
₹3,223 (+3.22%)
Indian investors sentiment towards Outlook Therapeutics
Global Institutional Holdings in Outlook Therapeutics
TANG CAPITAL MANAGEMENT LLC
6.52%
Great Point Partners LLC
5.41%
Vanguard Group Inc
3.58%
BlackRock Inc
2.78%
Altium Capital Management, LP
2.27%
Sphera Funds Management Ltd.
1.73%
Analyst Recommendation on Outlook Therapeutics
Buy
92%Buy
7%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Outlook Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Outlook Therapeutics
What analysts predicted
Upside of 946.41%
Current:
$2.37
Target:
$24.80
Insights on Outlook Therapeutics
Price Movement
In the last 7 days, OTLK stock has moved up by 20.4%OTLK vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 94.4%OTLK vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 146.7%Price to Sales
ForOTLK every $1 of sales, investors are willing to pay $18.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.
Outlook Therapeutics Technicals Summary
Sell
Neutral
Buy
Outlook Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Outlook Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 31.76% | -71.65% | -70.53% | -90.97% | -87.72% |
 | -8.86% | -31.87% | -20.46% | 15.59% | 87.28% |
 | -4.16% | 43.82% | 3.49% | -49.66% | 167.6% |
 | -8.45% | -8.03% | 19.03% | 56.02% | 98.44% |
 | -14.11% | -16.23% | -2.87% | 81.78% | 76.8% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -2.62 | -0.04 | -0.84 | NA | -3.57 |
| 17.61 | 17.61 | 1.06 | 45.07 | 0.17 | 0.07 | NA | 272.04 |
| 160.8 | NA | 0.04 | -3.11 | -0.02 | -0.01 | NA | 79.73 |
| NA | NA | -0.49 | -0.19 | -15.01 | -0.03 | NA | 0.25 |
| 32.84 | NA | 1.06 | 0.51 | -0.03 | 0.12 | NA | 60.65 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $47.1M | -87.72% | NA | 0.0% |
| Buy | $78.3B | 87.28% | 17.61 | 33.61% |
| Buy | $27.3B | 167.6% | 160.8 | -15.36% |
| Buy | $30.4B | 98.44% | NA | -15.86% |
| Buy | $103.7B | 76.8% | 32.84 | -4.51% |
About Outlook Therapeutics
Management People of Outlook Therapeutics
Important FAQs about investing in Outlook Therapeutics from India :
What is Outlook Therapeutics share price today?
Outlook Therapeutics share price today stands at $2.37, Open: $2.28 ; Previous Close: $2.24 ; High: $2.59 ; Low: $2.24 ; 52 Week High: $12.85 ; 52 Week Low: $0.87. The stock opens at $2.28, after a previous close of $2.24. The stock reached a daily high of $2.59 and a low of $2.24, with a 52-week high of $12.85 and a 52-week low of $0.87.
Can Indians buy Outlook Therapeutics shares?
Yes, Indians can invest in the Outlook Therapeutics (OTLK) from India.
With INDmoney, you can buy Outlook Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Outlook Therapeutics at zero transaction cost.
How can I buy Outlook Therapeutics shares from India?
It is very easy to buy Outlook Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Outlook Therapeutics be purchased?
Yes, you can buy fractional shares of Outlook Therapeutics with INDmoney app.
What are the documents required to start investing in Outlook Therapeutics stocks?
To start investing in Outlook Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Outlook Therapeutics
Today’s highest price of Outlook Therapeutics (OTLK) is $2.59.
Today’s lowest price of Outlook Therapeutics (OTLK) is $2.24.
What is today's market capitalisation of Outlook Therapeutics
What is the 52 Week High and Low Range of Outlook Therapeutics
52 Week High
$12.85
52 Week Low
$0.87
What are the historical returns of Outlook Therapeutics?
1 Month Returns
31.76%
3 Months Returns
-71.65%
1 Year Returns
-70.53%
5 Years Returns
-87.72%
